ABG Pharma

ABG Pharma (operating under the parent holding company Asia Biotech Group) is a Singapore-based pharmaceutical and biotechnology company focused on the research, development, and distribution of innovative medicines and vaccines. The company leverages its proprietary Adenoviral Vector and Epitope Platforms to develop a pipeline of next-generation vaccines and therapeutic agents targeting tropical infectious diseases and specialty conditions, such as dengue fever, influenza, hepatitis C, tuberculosis, and Amyotrophic Lateral Sclerosis (ALS). In addition to its R&D pipeline, ABG Pharma operates a robust distribution network across Southeast Asia (including Singapore, Malaysia, Indonesia, and the Philippines) and the EAEU region, supplying high-quality European-manufactured generic pharmaceuticals, oncology and neurology drugs, and clinical-grade food supplements.